IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

Research To Practice | Oncology Videos · Jun 24, 2025 · 54m

Featuring an interview with Dr Patrick Y Wen, including the following topics:

Glioma classification (0:00)

Efficacy and safety of vorasidenib in the management of IDH-mutant gliomas (4:50)

Case: A woman in her early 30s with a Grade 2 astrocytoma and an IDH R132H mutation and residual disease postoperatively (11:55)

Case: A man in his early 40s experiencing stable disease with vorasidenib after subtotal resection (21:46)

Ongoing trial investigating vorasidenib in IDH-mutant gliomas (27:30)

Current and emergent strategies for the management of glioblastoma (31:27)

Optimizing patient care and…